XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles
Recalling firm: Atlantic Pro Nutrients, Inc. dba XYMOGEN
Why it was recalled
Undeclared Soy and Milk on the label.
Check your package
Compare the exact product and package details with the label you have.
ProductXYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles
FDA code information
All SKUs
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles
Recall details
- Recall number
- F-1523-2013
- Event ID
- 65128
- FDA status
- Terminated
- Initiated
- May 1, 2013
- Reported
- Jun 19, 2013
- Classified
- Jun 11, 2013
- Terminated
- Jan 15, 2014
- Quantity
- 16,268 units
- Location
- Orlando, FL, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Where it was distributed
AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NJ, NM, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY, District of Columbia and Hawaii
FDA source record · F-1523-2013
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.